KELLY BOWEN: Open Payments
NPI 1558728568 · RUSHVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,563 in 53 payments from 14 companies in 2025. Trend: 2023 $3,299 · 2024 $2,669 · 2025 $1,563
Food & beverage: $1,563
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $481 |
| AstraZeneca Pharmaceuticals LP | 11 | $450 |
| Phathom Pharmaceuticals, Inc. | 1 | $130 |
| ABBVIE INC. | 5 | $105 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| Amgen Inc. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| PFIZER INC. | 2 | $42 |
Products named: Ozempic, AIRSUPRA, BREZTRI, Wegovy, VOQUEZNA, VRAYLAR, Kerendia, JARDIANCE.
Industry payments across NY — which companies pay providers there.
